- Home
- MODD vs ENZ Comparison
MODD vs ENZ Comparison
Compare MODD & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- ENZ
- Stock Information
- Founded
- MODD 1998
- ENZ 1976
- Country
- MODD United States
- ENZ United States
- Employees
- MODD N/A
- ENZ N/A
- Industry
- MODD Industrial Specialties
- ENZ Medical Specialities
- Sector
- MODD Health Care
- ENZ Health Care
- Exchange
- MODD Nasdaq
- ENZ Nasdaq
- Market Cap
- MODD 35.5M
- ENZ 34.2M
- IPO Year
- MODD N/A
- ENZ N/A
- Fundamental
- Price
- MODD $0.89
- ENZ $0.31
- Analyst Decision
- MODD
- ENZ
- Analyst Count
- MODD 0
- ENZ 0
- Target Price
- MODD N/A
- ENZ N/A
- AVG Volume (30 Days)
- MODD 155.4K
- ENZ 625.0K
- Earning Date
- MODD 02-13-2025
- ENZ 06-12-2025
- Dividend Yield
- MODD N/A
- ENZ 31.59%
- EPS Growth
- MODD N/A
- ENZ N/A
- EPS
- MODD N/A
- ENZ N/A
- Revenue
- MODD N/A
- ENZ $29,094,000.00
- Revenue This Year
- MODD N/A
- ENZ N/A
- Revenue Next Year
- MODD N/A
- ENZ N/A
- P/E Ratio
- MODD N/A
- ENZ N/A
- Revenue Growth
- MODD N/A
- ENZ N/A
- 52 Week Low
- MODD $0.68
- ENZ $0.25
- 52 Week High
- MODD $2.65
- ENZ $1.27
- Technical
- Relative Strength Index (RSI)
- MODD 43.99
- ENZ 39.61
- Support Level
- MODD $0.79
- ENZ $0.26
- Resistance Level
- MODD $0.95
- ENZ $0.42
- Average True Range (ATR)
- MODD 0.10
- ENZ 0.07
- MACD
- MODD -0.01
- ENZ 0.01
- Stochastic Oscillator
- MODD 28.42
- ENZ 35.29
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.